Qortora · Search · Indexed page

www.fxstreet.comFetched 2026-08-17T12:17:46Z

FXStreet - Forex & Crypto News

Latest forex analysis and market insights

Open original source · Full cached text

Forex Analysis TRENDING:Canada CPI Oil price XAU/USD EUR/USD GBP/USD Silver Newsletter UpgradeLogin Rates & Charts Charts Live chart Forecast poll Rates table Technical indicators Assets EUR/USD GBP/USD NZD/USD USD/CAD GBP/JPY EUR/JPY Dollar Index Gold Oil SP500 News News Forex news Institutional research Latest by asset EUR/USD USD/JPY AUD/USD NZD/USD USD/CAD USD/CHF EUR/GBP Dollar Index Commodities Bonds Analysis Analysis Forex analysis Editorial picks EUR/USD GBP/USD USD/JPY AUD/USD USD/CAD NZD/USD US Dollar Index Gold Oil Stocks Commodities Economic Calendar Economic calendar Economic calendar World interest rates Market hours Fed Sentiment Index Key events Fed Nonfarm payrolls US CPI BoC ECB BoE BoJ RBA RBNZ SNB Cryptos Crypto Crypto news Press releases Latest by asset Bitcoin Ethereum Ripple Cardano Solana Dogecoin Education Education Forex education Brokers Brokers Brokers Broker reviews Best of 2026 Press releases Trader cashback Prop Firms PropinderNEW Sponsored by Login Forex Analysis EUR/USD extends gains above 1.1600 on USD weakness EUR/USD extends its advance above 1.1600 in European trading hours on Monday. The US Dollar resumes its downside amid weaker-than-expected US economic data, shifting Fed expectations and fading geopolitical risk premium. GBP/USD hits fresh three-month highs above 1.3550 GBP/USD stretches north and refreshes three-month highs above 1.3500 in the European session on Monday. The prevalent US Dollar selling bias favors bullish traders and suggests that the path of least resistance for the pair remains to the upside. Gold sticks to gains near $4,400 as USD slumps to two-month low Gold maintains its bullish tone through the first half of the European session and currently trades around $4,400, up for the second straight day. The commodity, however, remains below the highest level since June 5, touched last Thursday, amid a mixed fundamental backdrop. Stocks PFE price outlook: Pfizer pressing against 0.618 arc. Potential breakout toward $27.95 Overview: Based on Arc Cycle Analysis applied to the 1D chart, Pfizer is interacting with the 0.618 Resistance Arc within the current Arc Cycle. Price is testing this Resistance Arc, suggesting the potential for a breakout toward the next Resistance Arc. Metric Latest Analysis 2 hours ago Dollar sell signal triggered [Video] Jason Sen 4 hours ago EUR/USD at eight-week high: What happens next RoboForex Analysis Department 7 hours ago EUR/USD to 1.1600? GBP/USD and AUD/USD test resist [Video] Kim Cramer Larsson 8 hours ago EUR/USD rally meets a crucial barrier with bulls on watch Aayush Jindal More Latest Analysis Broker Reviews Find independent, trusted reviews and choose your perfect broker. Access now Best brokers in your location Smart insights by real people. Every day. Stay ahead with key market trends from Orange Juice Newsletter. Mail* SubscribeYes, I also want to receive FXStreet promotions. By subscribing you agree to our T&Cs. In-Depth Analysis Why is Crude Oil priced for a reopening the ships haven't made? Fourteen vessels crossed the Strait of Hormuz on Tuesday. Before the war, the count ran near 120 a day. In the sessions since the waterway was publicly declared open, Brent has drifted back to $87 and West Texas Intermediate (WTI) to $81, both a little lower again on Wednesday, with daily momentum on each unwound from the top of its range in late July to the low twenties now. Why the WTI sell-off may be hiding a supply warning Prices for the barrel of the American Oil benchmark have fallen sharply as hopes of a US-Iran agreement have resurfaced, but a deeply backwardated Oil curve, tight Cushing stocks and light speculative positioning all warn that the sell-off may have gone too far. 911 million shares freed: Why SpaceX rallied into its own supply The most heavily trailed supply event of the year landed on August 6, and the SpaceX (SPCX) stock went up. Roughly 911.5 million shares held by insiders and early backers became eligible to trade, around 43% more than the entire float sold at the listing. FAQs What is Forex Analysis? What are the types of Forex Analysis? What indicator is best for Forex? How do you analyze trends in Forex? How do I create a Forex Strategy? How can beginners start trading forex? How do I get a forex signal? Best Brokers in 2026 Top Brokers in the MENA Region Best Prop Trading Firms in 2026 Five best Forex brokers in 2026 Best brokers in Indonesia Best brokers in Latin America - LATAM 2026 Best brokers to trade EUR/USD Brokers with Islamic and swap-free accounts Best Forex Brokers with low spreads in 2026 Best brokers to trade Gold Best CFD Brokers in 2026 Best Regulated Brokers in 2026 Best brokers with high leverage in 2026 Company About UsEditorial GuidelinesScore ReviewsEthical CodeCorporate IdentityTransparency TranslationsFXStreet BlogAI Usage Solutions PropinderNewsletterRSS FeedsSitemapAPI Documentation Legal Terms & ConditionsPrivacy PolicyCookie PolicyConsumer Advice Contact Us AdvertisingAdvertising ModelSubmit Request Company Solutions Legal Contact Us English ©2026 FXStreet All Rights Reserved Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page. If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet. FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted. The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.